EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression-Driven Genetic Dependency Reveals Targets for Precision Oncology

Abdulkadir Elmas iD, Hillary M Layden, Jacob D Ellis, Luke N Bartlett, Xian Zhao, Reika Kawabata-Iwakawa, Zishan Wang, Hideru Obinata, Scott W Hiebert, Kuan-Lin Huang iD

GigaScience · 2026

DOI: 10.1093/gigascience/giag011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GigaScience, 2026. Verfasst von Abdulkadir Elmas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Genomic Sciences, Department of Artificial Intelligence and Human Health, Center for Transformative Disease Modeling, Tisc…. Hauptthemen laut MEDLINE: Gene Expression Regulation, Neoplastic, Neoplasms, Precision Medicine. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, American Cancer Society, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer cells are heterogeneous, each harboring distinct molecular aberrations and being dependent on different genes for their survival and proliferation. While targeted therapies based on driver DNA mutations have shown success, many tumors lack druggable mutations, limiting treatment options. We hypothesize that new precision oncology targets may be identified through “expression-driven dependency,” where cancer cells with high expression of specific genes are more vulnerable to the knockout of those same genes.

Results

We developed BEACON, a Bayesian approach to identify expression-driven dependency targets by analyzing global transcriptomic and proteomic profiles alongside genetic dependency data from cancer cell lines across 17 tissue lineages. BEACON successfully identified known druggable genes, including BCL2, ERBB2, EGFR, ESR1, and MYC, while revealing novel targets confirmed by both mRNA and protein-expression driven dependency. The identified genes showed a 3.8-fold enrichment for approved drug targets and a 7 to 10-fold enrichment for druggable oncology targets. Experimental validation demonstrated that depletion of GRHL2, TP63, and PAX5 effectively reduced tumor cell growth and survival in their dependent cells.

Conclusions

Our approach provides a systematic method to identify precision oncology targets based on expression-driven dependency patterns. By integrating multi-omics data with genetic dependency screens, we’ve created a comprehensive catalog of potential therapeutic targets that may expand treatment options for cancer patients lacking druggable mutations. This resource offers new opportunities for precision oncology target discovery beyond mutation-based approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene Expression Regulation, NeoplasticNeoplasmsPrecision MedicineHumansCell Line, TumorGene Expression ProfilingProteomicsTranscriptomeBayes Theorem

Stichwörter der Autor:innen

BEACONBayesian statisticscancer cell linescancer vulnerabilitydrug targetsexpression-driven dependencymulti-omicsprecision oncologyproteomicstranscriptomics

Autor:innen und Institutionen

  • Department of Genetics and Genomic Sciences, Department of Artificial Intelligence and Human Health, Center for Transformative Disease Modeling, Tisch Cancer Institute, Icahn Genomics Institute, Icahn School of Medicine…
  • Department of Biochemistry, Vanderbilt University School of Medicine, 2209 Garland Avenue, Nashville, TN 37232, USA.
  • Department of Biochemistry, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
  • Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, 321 Zhongshan Road, Nanjing, Jiangsu 210008, China.
  • Division of Integrated Oncology Research, Gunma University Initiative for Advanced Research, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
  • Education and Research Support Center, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.

ORCID-Profile: Abdulkadir Elmas, Kuan-Lin Huang

Förderung

  • NIGMS NIH HHS
  • American Cancer Society
  • NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Elmas, A., Layden, H. M., Ellis, J. D., Bartlett, L. N., Zhao, X., Kawabata-Iwakawa, R., Wang, Z., Obinata, H., Hiebert, S. W., & Huang, K. L. (2026). Expression-Driven Genetic Dependency Reveals Targets for Precision Oncology. GigaScience. https://doi.org/10.1093/gigascience/giag011

Vancouver

Elmas A, Layden HM, Ellis JD, Bartlett LN, Zhao X, Kawabata-Iwakawa R, et al. Expression-Driven Genetic Dependency Reveals Targets for Precision Oncology. GigaScience. 2026. doi:10.1093/gigascience/giag011

BibTeX
@article{Elmas2026,
  author = {Elmas, Abdulkadir and Layden, Hillary M and Ellis, Jacob D and Bartlett, Luke N and Zhao, Xian and Kawabata-Iwakawa, Reika and Wang, Zishan and Obinata, Hideru and Hiebert, Scott W and Huang, Kuan-Lin},
  title = {Expression-Driven Genetic Dependency Reveals Targets for Precision Oncology},
  journal = {GigaScience},
  year = {2026},
  doi = {10.1093/gigascience/giag011}
}
Kostenlos starten →